Category Leader, Oncology & Rare Disease — Middle East

Pfizer Inc; Dubai; On-site; AED 600,000 - 1,000,000; Full time

Job summary

Pfizer Inc. in the Middle East seeks a strategic Category Lead for Oncology & Rare Disease to shape portfolio strategy, prioritise launches, and drive patient access across the region.

You will lead cross-functional teams across Commercial, Medical, Access & Value, Regulatory, and Public Affairs to deliver launch excellence and sustainable growth while strengthening category leadership and external engagement across markets.

Qualifications

• 10+ years of pharmaceutical/healthcare experience with substantial commercial leadership.
• Experience in Oncology, Rare Disease, or related portfolio preferred.
• Strong external orientation with ability to influence senior stakeholders across cultures and functions.

Responsibilities

• Translate ME Oncology & Rare Disease strategy into clear priorities for portfolio, brands, and markets.
• Lead end-to-end portfolio planning across in-line brands, new indications, and launches.
• Own category performance with clear direction on revenue, profitability, and resource deployment.
• Lead integrated launch readiness for new products and indications across Middle East markets.
• Define launch ambition, sequencing, and critical success factors; track milestones and governance.
• Develop lifecycle strategies to sustain growth and maximize portfolio value.
• Partner with Access, Value, Regulatory, Supply, Finance, and regional/global teams to align strategy and execution.

Skills

P&L management

Portfolio leadership

Strategic thinking

Executive presence

Education

Bachelor's degree in Life Sciences/Pharmacy/Medicine/Business

MBA or equivalent advanced degree

Job description

Pfizer Inc. in the Middle East seeks a strategic Category Lead for Oncology & Rare Disease to shape portfolio strategy, prioritise launches, and drive patient access across the region.

You will lead cross-functional teams across Commercial, Medical, Access & Value, Regulatory, and Public Affairs to deliver launch excellence and sustainable growth while strengthening category leadership and external engagement across markets.